SCOR (ENXTPA:SCR) After Japan Post Deal Looks Fairly Valued Or Still Misread
SCOR (ENXTPA:SCR) is back in focus after Japan Post Insurance signed a Memorandum of Understanding that would transfer Postal Life Insurance underwriting risks and create a shared reinsurance vehicle for risk diversification.
See our latest analysis for SCOR.
SCOR’s recent Memorandum of Understanding with Japan Post Insurance arrives at a time when momentum in the stock has been building, with a 1-month share price return of 5.36% and a year to date share price return of 17.16%, alongside a 5-year total shareholder return of 86.09% that reflects how the market has rewarded patient holders over time.
If this partnership has you thinking about where else risk and reward could line up, it might be worth scanning for other opportunities through the 105 top founder-led companies
SCOR now trades only slightly below analyst targets, yet still appears at a much larger discount to estimated intrinsic value. Is the market rightly cautious after the recent rally, or is it still underestimating what this business is worth?
Most Popular Narrative: 3% Undervalued
SCOR’s most followed valuation narrative pegs fair value at €33.92, only slightly above the last close of €33.04, which keeps attention firmly on the detailed assumptions behind that gap.
SCOR's data-driven underwriting and business diversification enhance profitability, resilience, and open access to new markets amid rising reinsurance demand from global volatility. Strong capital management and Life & Health growth position SCOR to benefit from regulatory shifts and ESG trends, supporting revenue expansion and shareholder value.
Curious what earnings path, revenue trajectory and margin profile are built into that valuation gap? The narrative rests on a carefully calibrated mix of growth assumptions and profitability trade offs. The full story is in how those inputs interact over time, not just the headline fair value.
Result: Fair Value of €33.92 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this SCOR narrative could be challenged if higher catastrophe exposure or ongoing legal disputes with Covéa begin to materially pressure earnings and capital strength.
Find out about the key risks to this SCOR narrative.
Next Steps
If the mixed sentiment around SCOR has you torn between caution and optimism, take action promptly and review the balance of risks and rewards for yourself through the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond SCOR?
If SCOR has sharpened your focus, do not stop here. Use the Simply Wall St screener to uncover more stocks that could fit your investment style.
- Target opportunities that combine quality and value by reviewing the 223 high quality undervalued stocks, which already clear fundamental checks and trade at appealing valuations.
- Strengthen your income focus by scanning the 472 dividend fortresses and seeing which companies currently offer higher yields supported by ongoing cash generation.
- Prioritise resilience in tougher markets by checking the 290 resilient stocks with low risk scores, which score well on stability factors and downside protection.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com